Preview

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology

Advanced search

Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia

https://doi.org/10.17749/2070-4909.2017.10.3.022-027

Full Text:

Abstract

Multiple sclerosis (MS) remains one of the most expensive diseases in the Russian healthcare system due to its early onset, increasing life expectancy of the patients, and the use of costly diagnostic methods and medical treatment. According to experts, even a slight reduction in direct (medical) expenses leads to a sharp increase in indirect costs; this situation necessitates an updated assessment of the number of MS patients, the degree of their disability, and the epidemiological dynamics of the disease. The aim of the study was to assess the economic damage associated with MS using the clinical, epidemiological, medical, and social data available for the city of Ufa. Materials and Methods. Direct medical expenses (outpatient care, visits to specialists, inpatient care, medications for outpatients), direct non-medical costs (temporary disability benefits, disability pensions, social services) were analyzed as well as the losses in the regional gross domestic product (GDP) due to temporary or permanent disability and premature mortality (indirect costs). Results. Because of MS only in the city Ufa, the Russian economy loses 428,222,026.35 rubles per year, mostly due to direct medical costs; of those, almost 50% is spent for immunomodulatory therapy (202,787,862.81 rubles). Annually, 4 596 245.76 rubles are spent for the hospital 24-hour treatment of MS patients, 916,154.28 rubles – for the daycare treatment, and 505,914.56 rubles – for outpatient care. Economic losses from premature death of MS patients in Ufa amounted to 21,570,999.52 rubles per year, and the lost GDP profit was estimated at 328,783,783 rubles. Conclusion. MS remains the leader of high-cost diseases and requires significant expenses from the state-run healthcare system in the Russian Federation. Epidemiological and pharmacoeconomic studies can help planning and modernizing the medical care for patients with multiple sclerosis. 

About the Authors

E. V. Ivanova
Bashkir State Medical University
Russian Federation

Ivanova Elena Vladimirovna – Postgraduate student with the Department of neurology, with courses of neurosurgery and medical genetics. 

Address: ul. Lenina, 3, Ufa, Republic Bashkortostan, 450003.



K. Z. Bachtiyarova
Bashkir State Medical University

Bahtijarova Klara Zakievna – MD, Professor at the Department of Neurology, with courses of neurosurgery and medical genetics. 

Address: ul. Lenina, 3, Ufa, Republic Bashkortostan, 450003.



References

1. Gusev E. I., Zavalishin I. A., Bojko A. N. Multiple sclerosis [Rassejannyj skleroz (in Russian)]. Mocow. 2011; 511 s.

2. Vlasov Ja. V., Kurapov M. A., Churakov M. V. Vestnik Roszdravnadzora (in Russian). 2011; 5: 70-77.

3. Shmidt T. E., Jahno N. N. Multiple sclerosis/. A guide for doctors. 5th edition [Rassejannyj skleroz. Rukovodstvo dlja vrachej 5-e izd (in Russian)]. Moscow. 2016; 19 s.

4. Habirov F. A., Shakirova D. H., Dun O. A., Hajbullin T. I. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2012; 5 (3): 47-50.

5. Ignat’eva V. I., Avksent’eva M. V. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2014; 7 (3): 3-11.

6. Sura M. V. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2015; 8 (4): 21-27.

7. Omel’janovskij V.V., Avksent’eva M.V., Derkach E. V., Sveshniko va N. D. Pediatricheskaja farmakologija (in Russian). 2011; 8 (3): 6-12.

8. Amato M. P., Battaglia M. A., Caputo D., Fattore G., Gerzeli S., Pitaro M., Reggio A., Trojano M., Mu. S.I. C. Study Group. The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-ill-ness study in Italy. J Neurol. 2002; 249: 152-163.

9. Kochetkova A. Ju., Tihonovskaja O. A., Alifirova V. M. Realizacija reproduktivnoj funkcii zhenshhin, stradajushhih rassejannym sklerozom. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction (in Russian). 2014; 8 (4): 73.

10. Official site of the State Committee of the Russian Federation on Statistics URL: http://www.gks.ru/ (in Russian). Accessed: 22.08.2017.

11. Ivanova E. V., Bahtijarova K. Z., Zaplahova O. V., Sharafutdinova L. R. Prakticheskaja medicina (in Russian). 2017; 1 (1): 88-92.

12. Official site of the State Register of Medicines. URL: http://www.grls.rosminzdrav.ru/ (in Russian). Accessed: 09.01.2017 g.

13. Tariff agreement on compulsory health insurance in the territory of the Republic of Bashkortostan for 2016 No. 51 of January 21, 2016 (as amended by Minutes No. 52 of 02.03.2016, No. 53 of 12 April 2016, No. 54 of May 25, 2016, No. 55 of May 30, 2016) [Tarifnoe soglashenie po objazatel’nomu medicinskomu strahovaniju na territorii Respubliki Bashkortostan na 2016 god №51 ot 21.01.2016 g. (s izmenenijami, vnesennymi Protokolami №52 ot 02.03.2016 g., №53 ot 12.04.2016 g., №54 ot 25.05.2016 g., №55 ot 30.05.2016 g.) (in Russian)].

14. Statistical form No. 14 “Information on the activities of hospitals”, approved by order of Rosstat of July 29, 2009, No. 154 for 2016 [Statisticheskaja forma №14 «Svedenija o dejatel’nosti stacionarov», utverzhdennaja prikazom Rosstata ot 29.07.2009 g. №154 za 2016 g. (in Russian)]

15. Official site of the Territorial Federal Service of State Statistics for the Republic of Bashkortostan. URL: http://bashstat.gks.ru. (in Russian). Accessed: 04.04.2017 g.

16. Official site of the Pension Fund of the Russian Federation URL: http://www.pfrf.ru/. (in Russian). Accessed: 22.08.2017.

17. Official website of the Ministry of Labor and Social Protection of the Republic of Bashkortostan. URL: https://mintrud.gov.by/ru. (in Russian). Accessed: 22.08.2017.


For citation:


Ivanova E.V., Bachtiyarova K.Z. Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2017;10(3):22-27. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.3.022-027

Views: 93


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)